- Retraction Note
- Open Access
Retraction Note: Genipin suppression of growth and metastasis in hepatocellular carcinoma through blocking activation of STAT-3
Journal of Experimental & Clinical Cancer Research volume 41, Article number: 102 (2022)
Retraction Note: J Exp Clin Cancer Res 39, 146 (2020)
The Editor-in-Chief has retracted this article. After publication concerns were raised with respect to the overlap of figures with a previously published article from another author group . Specifically:
Figure 1b, 1c, 1d, 1e and 1f with Figure 1c, 1d, 1e, 1f and 1h of Figure 1 of 
Figure 2 with Figure 2 of 
Figure 3b and 3c with Figure 3b and 3d of 
Figure 4b, 4c and 4d with Figure 4b, 4c and 4d of 
Figure 5 with Figure 5 of 
Figure 6 with Figure 6 of 
Figure 7 with Figure 7 of 
The Editor-in-Chief no longer has confidence in the results and conclusions reported. Ming Hong agrees with this retraction. Jacob Clayton, Wildman Yake and Jinke Li have not responded to correspondence from the Publisher about this retraction. The Publisher was not able to obtain a current email address for Selena Lee.
Zhang T, Li J, Yin F, et al. Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3. Oncogene. 2017;36:6627–39.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hong, M., Lee, S., Clayton, J. et al. Retraction Note: Genipin suppression of growth and metastasis in hepatocellular carcinoma through blocking activation of STAT-3. J Exp Clin Cancer Res 41, 102 (2022). https://doi.org/10.1186/s13046-022-02308-2